These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 14628732)

  • 1. Management of low-risk gestational trophoblastic neoplasia in indigent women.
    Schorge JO; Lea JS; Farrar DF; King MR; Coleman RL; Miller DS
    J Reprod Med; 2003 Oct; 48(10):780-4. PubMed ID: 14628732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-dose methotrexate regimen in the treatment of low-risk gestational trophoblastic neoplasia.
    Chan KK; Huang Y; Tam KF; Tse KY; Ngan HY
    Am J Obstet Gynecol; 2006 Nov; 195(5):1282-6. PubMed ID: 16723109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II trial of pulse dactinomycin as salvage therapy for failed low-risk gestational trophoblastic neoplasia: a Gynecologic Oncology Group study.
    Covens A; Filiaci VL; Burger RA; Osborne R; Chen MD;
    Cancer; 2006 Sep; 107(6):1280-6. PubMed ID: 16900525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methotrexate infusion and folinic acid as primary therapy for nonmetastatic and low-risk metastatic gestational trophoblastic tumors. 15 years of experience.
    Garrett AP; Garner EO; Goldstein DP; Berkowitz RS
    J Reprod Med; 2002 May; 47(5):355-62. PubMed ID: 12063874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Weekly methotrexate (50mg/m(2)) without dose escalation as a primary regimen for low-risk gestational trophoblastic neoplasia.
    Kang WD; Choi HS; Kim SM
    Gynecol Oncol; 2010 Jun; 117(3):477-80. PubMed ID: 20347479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment for low-risk gestational trophoblastic disease: comparison of single-agent methotrexate, dactinomycin and combination regimens.
    Abrão RA; de Andrade JM; Tiezzi DG; Marana HR; Candido dos Reis FJ; Clagnan WS
    Gynecol Oncol; 2008 Jan; 108(1):149-53. PubMed ID: 17931696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single-agent pulse dactinomycin has only modest activity for methotrexate-resistant gestational trophoblastic neoplasia.
    Chen LM; Lengyel ER; Bethan Powell C
    Gynecol Oncol; 2004 Jul; 94(1):204-7. PubMed ID: 15262143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-risk gestational trophoblastic neoplasia: evaluating the need for initial inpatient treatment during low-dose methotrexate chemotherapy.
    Carter LD; Hancock BW; Everard JE
    J Reprod Med; 2008 Jul; 53(7):525-7. PubMed ID: 18720928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of primary chemotherapy with single methotrexate on low-risk gestational trophoblastic neoplasia and influencing factors thereof].
    Chen YX; Shen YM; Qian JH; Xie X
    Zhonghua Yi Xue Za Zhi; 2005 Aug; 85(30):2109-12. PubMed ID: 16313819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of pulse methotrexate and pulse dactinomycin in the treatment of low-risk gestational trophoblastic neoplasia.
    Gilani MM; Yarandi F; Eftekhar Z; Hanjani P
    Aust N Z J Obstet Gynaecol; 2005 Apr; 45(2):161-4. PubMed ID: 15760322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relapse rate of patients with low-risk gestational trophoblastic tumor initially treated with single-agent chemotherapy.
    Matsui H; Suzuka K; Yamazawa K; Tanaka N; Mitsuhashi A; Seki K; Sekiya S
    Gynecol Oncol; 2005 Mar; 96(3):616-20. PubMed ID: 15721402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Combination chemotherapy with etoposide and cisplatin for high-risk, chemorefractory and recurrent gestational trophoblastic neoplasia].
    Jiang J; Nan FF; Yang XS; Zhang YZ; Wang B; Kong BH
    Zhonghua Fu Chan Ke Za Zhi; 2007 Sep; 42(9):595-9. PubMed ID: 17983513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluating methotrexate treatment in patients with low-risk postmolar gestational trophoblastic neoplasia.
    Growdon WB; Wolfberg AJ; Goldstein DP; Feltmate CM; Chinchilla ME; Lieberman ES; Berkowitz RS
    Gynecol Oncol; 2009 Feb; 112(2):353-7. PubMed ID: 19059633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemotherapy regimens used in the treatment of gestational trophoblastic neoplasia at Philippine General Hospital: treatment outcomes and toxicity.
    Cagayan MS; Gacoba MC
    J Reprod Med; 2006 Nov; 51(11):907-18. PubMed ID: 17165439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary treatment of metastatic high-risk gestational trophoblastic neoplasia with EMA-CO chemotherapy.
    Lurain JR; Singh DK; Schink JC
    J Reprod Med; 2006 Oct; 51(10):767-72. PubMed ID: 17086804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Weekly intramuscular methotrexate in the treatment of low-risk gestational trophoblastic neoplasia.
    Mohit M; Sarraf Z; Sheikhi G; Robati M; Vasheghani-Farahani A
    Arch Gynecol Obstet; 2009 Nov; 280(5):775-80. PubMed ID: 19263063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Single methotrexate chemotherapy for low-risk gestational trophoblastic tumor].
    Lu WG; Ding ZM; Xie X; Ye DF; Chen HZ; Feng SW
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Aug; 25(4):414-7. PubMed ID: 12974085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Weekly intravenous methotrexate with folinic acid for nonmetastatic gestational trophoblastic neoplasia.
    Kwon JS; Elit L; Mazurka J; Moens F; Schmuck ML
    Gynecol Oncol; 2001 Aug; 82(2):367-70. PubMed ID: 11531296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined methotrexate-dactinomycin: an effective therapy for low-risk gestational trophoblastic neoplasia.
    Eiriksson L; Wells T; Steed H; Schepansky A; Capstick V; Hoskins P; Pike J; Swenerton K
    Gynecol Oncol; 2012 Mar; 124(3):553-7. PubMed ID: 22079360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment results of methotrexate and folinic acid as primary chemotherapy for nonmetastatic gestational trophoblastic neoplasia.
    Srisomboon J; Suprasert P; Phongnarisorn C; Charoenkwan K; Siriaree S; Cheewakriangkrai C; Tantipalakorn C; Kietpeerakool C
    J Med Assoc Thai; 2005 Jul; 88(7):886-90. PubMed ID: 16241014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.